G93.44 ICD-10-CM Code: Adult-onset leukodystrophy with axonal spheroids
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the nervous system (G00-G99) / Other disorders of the nervous system (G89-G99)
G93.44
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceAdult-onset leukodystrophy with axonal spheroids
A rare adult-onset inherited brain disorder affecting white matter with characteristic spheroid structures in nerve fibers.

Buddy Insight
Adult-onset leukodystrophy with axonal spheroids (ALSP, also known as hereditary diffuse leukoencephalopathy with spheroids) is a progressive neurodegenerative white matter disease caused by CSF1R gene mutations.
CMS-HCC V28
MappedHCC 200
RAF 0.262
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
Official- Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Excludes 2
Official- alcoholic encephalopathy (G31.2)
- encephalopathy in diseases classified elsewhere (G94)
- hypertensive encephalopathy (I67.4)
- toxic (metabolic) encephalopathy (G92.8)
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for G93.44 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for G93.44 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for G93.44 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for G93.44 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for G93.44 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is G93.44 an HCC code?
Yes. G93.44 maps to Cerebellar Ataxia and Other Degenerative Diseases of Nervous System under the CMS-HCC V28 risk adjustment model.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G93.44
For G93.44to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G93.44 during that encounter, not just copy-forwarded from a problem list.
What This Code Means
G93.44 is the ICD-10-CM diagnosis code for adult-onset leukodystrophy with axonal spheroids. A rare adult-onset inherited brain disorder affecting white matter with characteristic spheroid structures in nerve fibers. G93.44 sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering other disorders of the nervous system (g89-g99).
Under the CMS-HCC V28 risk adjustment model, G93.44 maps to Cerebellar Ataxia and Other Degenerative Diseases of Nervous System (HCC 200) with a community, non-dual, aged base RAF weight of 0.262. G93.44 was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
This is a specific leukodystrophy with adult onset; document age of symptom onset. Because G93.44 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G93.44 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is a specific leukodystrophy with adult onset; document age of symptom onset
- •Pathological findings of axonal spheroids help confirm this diagnosis
Clinical Significance
Adult-onset leukodystrophy with axonal spheroids (ALSP, also known as hereditary diffuse leukoencephalopathy with spheroids) is a progressive neurodegenerative white matter disease caused by CSF1R gene mutations. It typically presents in the third to fifth decade with behavioral changes, cognitive decline, and motor dysfunction that may mimic frontotemporal dementia or multiple sclerosis. Accurate diagnosis is critical for genetic counseling and distinguishing from treatable conditions.
Documentation Requirements
- ✓Genetic testing confirming CSF1R gene mutation
- ✓MRI demonstrating progressive white matter changes with frontal predominance
- ✓Clinical documentation of adult onset with progressive cognitive, behavioral, or motor decline
- ✓Neuropathology findings if available (axonal spheroids on biopsy)
- ✓Family history assessment for autosomal dominant inheritance pattern
Commonly Confused Codes
- •G35: Multiple sclerosis: relapsing-remitting course, different imaging pattern, no genetic basis
- •G31.09: Other frontotemporal dementia: may present similarly but lacks the white matter changes and genetic mutation
- •G93.42: Megalencephalic leukoencephalopathy with subcortical cysts: childhood onset, different genetic cause
- •G90.B: LMNB1-related leukodystrophy: different gene (LMNB1 vs CSF1R), different clinical progression